1. A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B‐cell lymphoma. (23rd August 2013) Authors: Coiffier, Bertrand; Radford, John; Bosly, André; Martinelli, Giovanni; Barca, Gabriela; Davies, Andrew; Decaudin, Didier; Gallop‐Evans, Eve; Padmanabhan‐Iyer, Swaminathan; Van, Koen; Wu, Ka Lung; Gupta, Ira V.; Lin, Thomas S.; Goldstein, Nancy; Jewell, Roxanne C.; Winter, Paul; Lisby, Steen Journal: British journal of haematology Issue: Volume 163:Number 3(2013:Nov.) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL. Issue 9 (3rd July 2016) Authors: Flinn, Ian W.; Panayiotidis, Panayiotis; Afanasyev, Boris; Janssens, Ann; Grosicki, Sebastian; Homenda, Wojciech; Smolej, Lukas; Kuliczkowski, Kazimierz; Doubek, Michael; Domnikova, Natalia; West, Sarah L.; Chang, Chai‐Ni; Barker, Alison M.; Gupta, Ira V.; Wright, Oliver J.; Offner, Fritz Journal: American journal of hematology Issue: Volume 91:Issue 9(2016:Sep.) Page Start: 900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Health-related quality of life and patient-reported outcomes of ofatumumab plus fludarabine and cyclophosphamide versus fludarabine and cyclophosphamide in the COMPLEMENT 2 trial of patients with relapsed CLL. Issue 7 (3rd July 2017) Authors: Robak, Tadeusz; Warzocha, Krzysztof; Govind Babu, K.; Kulyaba, Yaroslav; Kuliczkowski, Kazimierz; Abdulkadyrov, Kudrat; Loscertales, Javier; Kryachok, Iryna; Kłoczko, Janusz; Rekhtman, Grygoriy; Homenda, Wojciech; Błoński, Jerzy Z.; McKeown, Astrid; Chang, Chai-Ni; Bal, Vasudha; Lisby, Steen; Gup... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 7(2017) Page Start: 1598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial. Issue 5 (4th May 2017) Authors: Robak, Tadeusz; Warzocha, Krzysztof; Govind Babu, K.; Kulyaba, Yaroslav; Kuliczkowski, Kazimierz; Abdulkadyrov, Kudrat; Loscertales, Javier; Kryachok, Iryna; Kłoczko, Janusz; Rekhtman, Grygoriy; Homenda, Wojciech; Błoński, Jerzy Z.; McKeown, Astrid; Gorczyca, Michele M.; Carey, Jodi L.; Chang, Ch... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 5(2017) Page Start: 1084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ofatumumab retreatment and maintenance in fludarabine‐refractory chronic lymphocytic leukaemia patients. (30th March 2015) Authors: Österborg, Anders; Wierda, William G.; Mayer, Jiří; Hess, Georg; Hillmen, Peter; Schetelig, Johannes; Schuh, Anna; Smolej, Lukáš; Beck, Christian; Dreyfus, Brigitte; Hellman, Andrzej; Kozlowski, Piotr; Pfreundschuh, Michael; Rizzi, Rita; Spacek, Martin; Phillips, Jennifer L.; Gupta, Ira V.; Willi... Journal: British journal of haematology Issue: Volume 170:Number 1(2015:Jul.) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗